Drug:
Reaction: COVID-19
20250101 - 20251231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 25846204 |
US |
51 | 2 |
COVID-19, Dyspnoea, Sinusitis, Oropharyngeal pain, Headache, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 102 | 25846295 |
US |
71 | 2 |
COVID-19, |
||||
DUPILUMAB, |
||||
| 103 | 25846584 |
CA |
||
Allergy to animal, Chills, Chronic spontaneous urticaria, Condition aggravated, Cough, Decreased appetite, Food allergy, Gallbladder disorder, Respiratory tract infection, Malaise, Nasal congestion, Oropharyngeal pain, Pain, Scar, COVID-19, Dizziness, Hypersensitivity, Nausea, Pruritus, Pyrexia, Urticaria, Abdominal pain upper, Nasopharyngitis, Adverse drug reaction, Therapeutic product effect decreased, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, HYDROXYZINE, HYDROXYZINE, CYANOCOBALAMIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 104 | 25846632 |
CA |
73 | 1 |
Condition aggravated, Hypersomnia, Fatigue, COVID-19, Nasopharyngitis, Viral infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, |
||||
| 105 | 25846664 |
US |
75 | 2 |
COVID-19, |
||||
DUPILUMAB, |
||||
| 106 | 25846716 |
69 | 2 | |
COVID-19, |
||||
SECUKINUMAB, |
||||
| 107 | 25846970 |
US |
||
COVID-19, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 108 | 25847057 |
US |
36 | 1 |
Haematochezia, COVID-19, Muscle tightness, |
||||
VEDOLIZUMAB, |
||||
| 109 | 25847142 |
EU |
||
Infection, Lower respiratory tract infection, COVID-19, |
||||
BORTEZOMIB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 110 | 25847338 |
|||
Pneumonia, COVID-19, |
||||
RUXOLITINIB, |
||||
| 111 | 25847439 |
US |
2 | |
COVID-19, |
||||
SARILUMAB, |
||||
| 112 | 25847675 |
US |
1 | |
COVID-19, |
||||
ELOSULFASE ALFA, EPINEPHRINE, ADRENALINUM, |
||||
| 113 | 25848202 |
US |
76 | 2 |
COVID-19, |
||||
POMALIDOMIDE, |
||||
| 114 | 25848443 |
US |
38 | 1 |
Lung infiltration, COVID-19, Pyrexia, Dyspnoea, Cough, Diabetic ketoacidosis, Blood glucose increased, Vomiting, |
||||
INSULIN DETEMIR, INSULIN ASPART, |
||||
| 115 | 25848827 |
US |
46 | 2 |
COVID-19, Immune system disorder, |
||||
| 116 | 25848907 |
US |
||
Tachycardia, COVID-19, |
||||
PHENTERMINE AND TOPIRAMATE, |
||||
| 117 | 25848908 |
US |
||
COVID-19, |
||||
PHENTERMINE AND TOPIRAMATE, |
||||
| 118 | 25848912 |
US |
||
COVID-19, |
||||
PHENTERMINE AND TOPIRAMATE, |
||||
| 119 | 25849121 |
JP |
66 | 2 |
Cytomegalovirus chorioretinitis, Mouth ulceration, Septic shock, Neutrophil count decreased, Cytokine release syndrome, COVID-19, Platelet count decreased, Haemoglobin decreased, |
||||
LISOCABTAGENE MARALEUCEL, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, FLUCONAZOLE, |
||||
| 120 | 25849189 |
US |
45 | 2 |
COVID-19, |
||||
DUPILUMAB, |
||||
| 121 | 25849312 |
US |
61 | 2 |
COVID-19, |
||||
LENALIDOMIDE, |
||||
| 122 | 25849417 |
US |
1 | |
Pulmonary embolism, COVID-19, |
||||
UPADACITINIB, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, |
||||
| 123 | 25849452 |
US |
88 | 1 |
COVID-19, |
||||
LENALIDOMIDE, |
||||
| 124 | 25838889 |
US |
2 | |
Influenza, COVID-19, |
||||
OMALIZUMAB, |
||||
| 125 | 25838990 |
JP |
62 | 2 |
COVID-19, Rash, Treatment noncompliance, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB FOR INJECTION, BORTEZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, LENALIDOMIDE, IXAZOMIB, ISATUXIMAB, ISATUXIMAB, POMALIDOMIDE, CARFILZOMIB, |
||||
| 126 | 25839061 |
NZ |
19 | 2 |
COVID-19, Drug ineffective for unapproved indication, |
||||
INFLIXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METHYLPREDNISOLONE, RITUXIMAB, |
||||
| 127 | 25839206 |
CA |
70 | 1 |
Arthralgia, COVID-19, Condition aggravated, |
||||
RITUXIMAB, RITUXIMAB, PREDNISONE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 128 | 25839452 |
EU |
2 | |
Cystitis, Loss of personal independence in daily activities, COVID-19, |
||||
ETANERCEPT, |
||||
| 129 | 25839592 |
CA |
84 | 2 |
Blood pressure fluctuation, COVID-19, Cough, Fatigue, Neck pain, Pain, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, METHYLPREDNISOLONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 130 | 25839595 |
US |
2 | |
COVID-19, Asthma, Pyrexia, Heat exhaustion, Stress, Injury, Pain, |
||||
ICATIBANT ACETATE, OMALIZUMAB, LANADELUMAB-FLYO, |
||||
| 131 | 25839996 |
US |
67 | 2 |
Cardiac flutter, Extrasystoles, COVID-19, |
||||
OMALIZUMAB, |
||||
| 132 | 25840353 |
JP |
||
Neutropenia, Lymphopenia, Anaemia, Leukopenia, Thrombocytopenia, Gastroenteritis, Cytokine release syndrome, Dermatitis bullous, Pneumonia, Plasma cell myeloma, Hypogammaglobulinaemia, Hypercalcaemia of malignancy, Adverse event, Hypoxia, Upper respiratory tract infection, COVID-19, Conjunctival haemorrhage, Weight decreased, Pyrexia, Injection site erythema, Malaise, Injection site warmth, Hypogeusia, Dysgeusia, Dyskinesia, Taste disorder, Diarrhoea, Nausea, Dysphagia, Vomiting, Abdominal pain, Aphthous ulcer, Constipation, Dry mouth, Gastrooesophageal reflux disease, Irritable bowel syndrome, Stomatitis, Alopecia, Skin exfoliation, Eczema, Nail disorder, Dry skin, Eczema nummular, Erythema, Hand dermatitis, Nail discolouration, Onychomadesis, Pruritus, Rash, Rash maculo-papular, Dermatophytosis of nail, Herpes zoster, Nasopharyngitis, Otitis media, Tinea pedis, Hyperglycaemia, Hypozincaemia, Decreased appetite, Hyperammonaemia, Arthralgia, Joint range of motion decreased, Muscular weakness, Myalgia, Neck pain, Spinal deformity, Tinnitus, Vertigo, Alanine aminotransferase increased, Aspartate aminotransferase increased, Lipase increased, Cancer pain, Skin papilloma, Tumour associated fever, Hiccups, Oropharyngeal pain, Rhinorrhoea, Diplopia, Dry eye, Nail avulsion, Mental disorder, Insomnia, Anxiety, Bundle branch block right, Prostatic obstruction, |
||||
CARFILZOMIB, FILGRASTIM, TALQUETAMAB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, IXAZOMIB, THALIDOMIDE, LENALIDOMIDE, POMALIDOMIDE, ISATUXIMAB, ACYCLOVIR, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, ZINC ACETATE, |
||||
| 133 | 25840445 |
US |
||
COVID-19, Body temperature increased, Fall, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 134 | 25840984 |
US |
||
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 135 | 25840996 |
US |
61 | 2 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 136 | 25841234 |
US |
||
COVID-19, Blood alkaline phosphatase increased, Blood bilirubin increased, Aspartate aminotransferase increased, Urticaria, |
||||
RESMETIROM, AMLODIPINE BESYLATE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ATORVASTATIN CALCIUM, AZITHROMYCIN DIHYDRATE, MAGNESIUM HYDROXIDE, POLYETHYLENE GLYCOL 3350, EZETIMIBE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, LINACLOTIDE, METHOCARBAMOL, OMEPRAZOLE MAGNESIUM, PITAVASTATIN CALCIUM, RISEDRONATE SODIUM, |
||||
| 137 | 25841311 |
US |
81 | 2 |
COVID-19, |
||||
LENALIDOMIDE, |
||||
| 138 | 25841530 |
US |
2 | |
COVID-19, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 139 | 25841633 |
US |
61 | 1 |
Pneumonia, Treatment failure, Mania, COVID-19, Asthma, |
||||
PREDNISONE, PREDNISONE, ITRACONAZOLE, FLUTICASONE FUROATE, UMECLIDINIUM, |
||||
| 140 | 25841839 |
EU |
38 | 2 |
Plasma cell myeloma, COVID-19, Thrombocytopenia, Anaemia, Nausea, Mucosal inflammation, Diarrhoea, Infection, Off label use, |
||||
FILGRASTIM, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, LOMUSTINE, CYTARABINE, MELPHALAN HYDROCHLORIDE, MELPHALAN, CYTARABINE, |
||||
| 141 | 25841929 |
CA |
2 | 1 |
Vascular device infection, Diarrhoea, Obesity, Dry skin, Yellow skin, COVID-19, Rhinovirus infection, Dermatitis contact, Gamma-glutamyltransferase increased, Alanine aminotransferase increased, Weight increased, Drug effect less than expected, Infrequent bowel movements, Illness, Abnormal faeces, Weight abnormal, Erythema, Decreased appetite, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 142 | 25842349 |
US |
64 | 2 |
COVID-19, Meniscus injury, Diverticulum intestinal, |
||||
TOFACITINIB, ESTRADIOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 143 | 25842350 |
US |
47 | 1 |
COVID-19, |
||||
RITLECITINIB, |
||||
| 144 | 25842365 |
US |
78 | 2 |
COVID-19, |
||||
PALBOCICLIB, |
||||
| 145 | 25842555 |
US |
2 | |
COVID-19, |
||||
DAPAGLIFLOZIN, |
||||
| 146 | 25842669 |
GB |
48 | 1 |
Brief resolved unexplained event, Meningitis, Seizure, Encephalitis, Atrial fibrillation, Left ventricular hypertrophy, Brain injury, Syncope, Fall, Bacterial test positive, Headache, Tonic clonic movements, Fungal infection, Bacteraemia, Memory impairment, Pyrexia, Tachycardia, Otitis externa, Lower respiratory tract infection, Hallucination, Myelopathy, Intensive care unit acquired weakness, COVID-19, Buttock injury, Vasogenic cerebral oedema, Visual impairment, Cognitive disorder, Spinal pain, Testicular pain, Arthralgia, Arthritis, Diabetes mellitus, Joint dislocation, Nystagmus, Tinnitus, Oropharyngeal pain, Delirium, Encephalomyelitis, Asthma, Tremor, Brain fog, Encephalopathy, Urinary incontinence, Cough, VIIth nerve injury, Agitation, Back pain, Dry eye, White blood cell count abnormal, Malaise, Muscular weakness, Spinal osteoarthritis, Joint dislocation, Amnesia, Skin abrasion, Immunisation reaction, |
||||
ALENDRONATE SODIUM, PHENOBARBITAL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, THIAMINE HYDROCHLORIDE, LACOSAMIDE, MIRABEGRON, GABAPENTIN, BUDESONIDE, ALBUTEROL SULFATE, ALBUTEROL, CLARITHROMYCIN, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, PROPOFOL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, FUROSEMIDE, |
||||
| 147 | 25842733 |
CA |
76 | 1 |
COVID-19, Chest injury, Decreased appetite, Headache, Fatigue, Weight decreased, Constipation, Dry mouth, Oedema, Infusion site reaction, Cognitive disorder, Palmar-plantar erythrodysaesthesia syndrome, Fall, Musculoskeletal chest pain, Off label use, |
||||
ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, ELRANATAMAB-BCMM, |
||||
| 148 | 25842758 |
US |
2 | |
COVID-19, Device issue, Device malfunction, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 149 | 25842945 |
GB |
2 | |
COVID-19, |
||||
UPADACITINIB, |
||||
| 150 | 25843089 |
US |
2 | |
Illness, COVID-19, |
||||
SARILUMAB, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, LEVOTHYROXINE, |
||||
| 151 | 25843701 |
US |
57 | 1 |
Hospitalisation, Red blood cell count decreased, Influenza like illness, Decreased appetite, Balance disorder, Gait disturbance, CSF white blood cell count decreased, Investigation abnormal, Fall, Rheumatoid arthritis, COVID-19, Sepsis, Sciatica, Staphylococcal infection, Dysstasia, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 152 | 25843818 |
US |
75 | 2 |
COVID-19, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 153 | 25843834 |
CA |
||
Abdominal pain, Angioedema, Anxiety, Blood pressure systolic increased, COVID-19, Cough, Dizziness, Dysphonia, Dyspnoea, Eye pruritus, Hypoaesthesia, Laryngeal dyskinesia, Oropharyngeal pain, Paraesthesia, Photophobia, Pruritus, Pyrexia, Rhinorrhoea, Seizure, Swelling, Swelling face, Throat tightness, Urticaria, Wheezing, Anaphylactic reaction, Headache, Illness, Injection site erythema, Injection site swelling, Nasopharyngitis, Sinusitis, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, ONABOTULINUMTOXINA, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FAMOTIDINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, SERTRALINE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 154 | 25833789 |
US |
||
Feeling abnormal, COVID-19, Streptococcal infection, |
||||
ADALIMUMAB, |
||||
| 155 | 25833877 |
US |
29 | 1 |
COVID-19, |
||||
DUPILUMAB, |
||||
| 156 | 25833937 |
US |
2 | |
COVID-19, Drug ineffective, Drug resistance, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, RIMABOTULINUMTOXINB, |
||||
| 157 | 25834214 |
US |
1 | |
COVID-19, |
||||
GALCANEZUMAB-GNLM, |
||||
| 158 | 25834270 |
EU |
1 | |
Hypothyroidism, Hypertension, Urinary incontinence, Hypotension, Coronary artery occlusion, Fatigue, COVID-19, |
||||
APALUTAMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 159 | 25834649 |
US |
2 | |
COVID-19, Rheumatoid arthritis, |
||||
UPADACITINIB, |
||||
| 160 | 25834798 |
US |
2 | |
COVID-19, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, SPIRONOLACTONE, MONTELUKAST SODIUM, PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION, PREDNISONE, MACITENTAN, LISINOPRIL AND HYDROCHLOROTHIAZIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, FUROSEMIDE, TADALAFIL, CELECOXIB, ERGOCALCIFEROL, OXYGEN, 0XYGEN, DIPHENHYDRAMINE HYDROCHLORIDE, FERROUS SULFATE, |
||||
| 161 | 25834869 |
US |
61 | 2 |
COVID-19, |
||||
ABATACEPT, |
||||
| 162 | 25834934 |
US |
55 | 2 |
Migraine, COVID-19, Cough, Headache, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 163 | 25834964 |
US |
2 | |
COVID-19, |
||||
DUPILUMAB, |
||||
| 164 | 25836480 |
CA |
1 | |
Hospitalisation, Deep vein thrombosis, Myocardial infarction, COVID-19, Off label use, Urticaria, Rash, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, POMALIDOMIDE, |
||||
| 165 | 25836517 |
US |
81 | 2 |
Pneumonia, Asthenia, Cough, COVID-19, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 166 | 25836528 |
US |
49 | 1 |
COVID-19, |
||||
BUDESONIDE, LISINOPRIL, FAMOTIDINE, METHOCARBAMOL, METHOCARBAMOL TABLETS, AMLODIPINE BESYLATE, FISH OIL, |
||||
| 167 | 25836548 |
CA |
34 | 2 |
Ankylosing spondylitis, Arthralgia, Cough, Fatigue, Joint swelling, Laryngitis, Malaise, Musculoskeletal stiffness, Neck pain, Reaction to excipient, Pharyngeal paraesthesia, Pneumonia, COVID-19, Pyrexia, Rubber sensitivity, Sinusitis, Tachycardia, Tonsillitis, Vaginal infection, Off label use, |
||||
PANTOPRAZOLE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CODEINE SULFATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, FOLIC ACID, MELOXICAM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 168 | 25836565 |
81 | 1 | |
COVID-19, |
||||
APREMILAST, |
||||
| 169 | 25836767 |
US |
33 | 2 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DROSPIRENONE, |
||||
| 170 | 25836770 |
US |
72 | 2 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 171 | 25836789 |
US |
79 | 1 |
COVID-19, |
||||
POMALIDOMIDE, |
||||
| 172 | 25837139 |
US |
67 | 2 |
COVID-19, Disease recurrence, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 173 | 25837260 |
CN |
2 | |
Hypertension, Abdominal pain upper, Hypotension, Toothache, Gingival swelling, Noninfective gingivitis, COVID-19, Dizziness, Plicated tongue, Taste disorder, Oral mucosal roughening, Weight decreased, Mouth ulceration, Vomiting, Diarrhoea, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, |
||||
| 174 | 25837448 |
US |
24 | 2 |
COVID-19, Oropharyngeal pain, |
||||
ELOSULFASE ALFA, |
||||
| 175 | 25837453 |
US |
1 | |
COVID-19, Pyrexia, |
||||
ELOSULFASE ALFA, EPINEPHRINE, ADRENALINUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LIDOCAINE, |
||||
| 176 | 25837511 |
US |
2 | |
COVID-19, Infection, |
||||
ELAFIBRANOR, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ROSUVASTATIN CALCIUM, ALENDRONATE SODIUM, URSODIOL, URSOSIOL, LOSARTAN POTASSIUM, LOSARTAN, AMMONIA INHALANT, PAROXETINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 177 | 25837706 |
US |
72 | 1 |
COVID-19, |
||||
INSULIN GLARGINE, |
||||
| 178 | 25837755 |
TW |
65 | 1 |
Follicular lymphoma, Swelling, Cardiac dysfunction, COVID-19, |
||||
GLOFITAMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, OXALIPLATIN, BENDAMUSTINE HCL, |
||||
| 179 | 25838059 |
US |
81 | 1 |
Diabetes mellitus, COVID-19, Multiple allergies, Seasonal allergy, Localised infection, Illness, Influenza, Infusion site pruritus, Infusion site erythema, Fatigue, |
||||
HUMAN IMMUNOGLOBULIN G, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ATENOLOL, ISOSORBIDE DINITRATE, EMPAGLIFLOZIN, EPINEPHRINE, ADRENALINUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, NIACIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CAPSULES, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, INSULIN GLARGINE, ISOTRETINOIN, ESCITALOPRAM OXALATE, ESCITALOPRAM, TAMSULOSIN HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE, LEVOTHYROXINE, ERGOCALCIFEROL, LIDOCAINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, CHLORPROMAZINE, |
||||
| 180 | 25838450 |
US |
21 | 1 |
Infusion site discomfort, COVID-19, |
||||
MIRIKIZUMAB-MRKZ, MIRIKIZUMAB-MRKZ, MIRIKIZUMAB-MRKZ, |
||||
| 181 | 25838526 |
US |
2 | |
COVID-19, |
||||
DUPILUMAB, |
||||
| 182 | 25838558 |
US |
1 | |
COVID-19, Pneumonia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, LEVALBUTEROL TARTRATE, MAGNESIUM, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, QUETIAPINE FUMARATE, QUETIAPINE, SERTRALINE HYDROCHLORIDE, LEVALBUTEROL TARTRATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, FINASTERIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 183 | 25847020 |
2 | ||
Urinary tract infection, COVID-19, |
||||
ETANERCEPT, |
||||
| 184 | 25828536 |
JP |
75 | 1 |
Bile duct cancer recurrent, COVID-19, |
||||
DURVALUMAB, |
||||
| 185 | 25828616 |
US |
20 | 2 |
Product storage error, COVID-19, |
||||
RISANKIZUMAB-RZAA, |
||||
| 186 | 25828632 |
JP |
71 | 2 |
Skin ulcer, COVID-19, |
||||
RAVULIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 187 | 25828981 |
US |
45 | 2 |
COVID-19, Nasal congestion, Cough, |
||||
DUPILUMAB, |
||||
| 188 | 25829185 |
EU |
||
Immune system disorder, Dengue viraemia, COVID-19, Product use in unapproved indication, |
||||
RITUXIMAB, ENTECAVIR, ENTECAVIR ANHYDROUS, ENTECAVIR, ENTECAVIR ANHYDROUS, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, AZATHIOPRINE, |
||||
| 189 | 25829446 |
JP |
||
COVID-19, |
||||
IPILIMUMAB, NIVOLUMAB, |
||||
| 190 | 25829500 |
CA |
53 | 2 |
Blindness transient, COVID-19, Cough, Eye infection, Glomerular filtration rate abnormal, Joint range of motion decreased, Musculoskeletal pain, Transient ischaemic attack, Nausea, Ophthalmic migraine, Pharyngitis, |
||||
ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, ROSUVASTATIN, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 191 | 25829512 |
CA |
79 | 2 |
Abdominal pain upper, Balance disorder, COVID-19, Erythema, Fatigue, Hypoaesthesia, Muscular weakness, Nasopharyngitis, Off label use, Oropharyngeal discomfort, Pharyngeal paraesthesia, Photosensitivity reaction, Renal impairment, Skin plaque, Systemic lupus erythematosus, Urinary tract infection, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
| 192 | 25829658 |
US |
2 | |
Post procedural complication, COVID-19, Surgery, |
||||
AMBRISENTAN, |
||||
| 193 | 25829709 |
US |
62 | 2 |
COVID-19, |
||||
UPADACITINIB, |
||||
| 194 | 25829913 |
US |
1 | |
COVID-19, Pyrexia, Pneumonia bacterial, Productive cough, Fatigue, Malaise, Diarrhoea, Decreased appetite, |
||||
BLINATUMOMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, CYTARABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DOXORUBICIN, MERCAPTOPURINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB, VINCRISTINE SULFATE, VINCRISTINE SULFATE, |
||||
| 195 | 25829944 |
US |
2 | |
COVID-19, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, LOSARTAN POTASSIUM, LOSARTAN, TIRZEPATIDE, PROMETHAZINE, |
||||
| 196 | 25829979 |
US |
60 | 1 |
Gastrooesophageal reflux disease, Inappropriate schedule of product administration, COVID-19, Pyrexia, |
||||
ACALABRUTINIB, AMLODIPINE, |
||||
| 197 | 25830062 |
US |
83 | 1 |
COVID-19, Dyspnoea, Cough, Diarrhoea, Asthenia, Headache, Bradycardia, Chronic obstructive pulmonary disease, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 198 | 25830453 |
JP |
||
COVID-19, Acute respiratory distress syndrome, |
||||
RITUXIMAB, |
||||
| 199 | 25830530 |
GB |
1 | |
Colitis ulcerative, COVID-19, Tooth infection, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 200 | 25830707 |
US |
2 | |
COVID-19, Cystic fibrosis, |
||||
DORNASE ALFA, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, TOBRAMYCIN SULFATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30